Literature DB >> 19089844

PEL: an unbiased method for estimating age-dependent genetic disease risk from pedigree data unselected for family history.

F Alarcon1, C Bourgain, M Gauthier-Villars, V Planté-Bordeneuve, D Stoppa-Lyonnet, C Bonaïti-Pellié.   

Abstract

Providing valid risk estimates of a genetic disease with variable age of onset is a major challenge for prevention strategies. When data are obtained from pedigrees ascertained through affected individuals, an adjustment for ascertainment bias is necessary. This article focuses on ascertainment through at least one affected and presents an estimation method based on maximum likelihood, called the Proband's phenotype exclusion likelihood or PEL for estimating age-dependent penetrance using disease status and genotypic information of family members in pedigrees unselected for family history. We studied the properties of the PEL and compared with another method, the prospective likelihood, in terms of bias and efficiency in risk estimate. For that purpose, family samples were simulated under various disease risk models and under various ascertainment patterns. We showed that, whatever the genetic model and the ascertainment scheme, the PEL provided unbiased estimates, whereas the prospective likelihood exhibited some bias in a number of situations. As an illustration, we estimated the disease risk for transthyretin amyloid neuropathy from a French sample and a Portuguese sample and for BRCA1/2 associated breast cancer from a sample ascertained on early-onset breast cancer cases. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19089844      PMCID: PMC3108000          DOI: 10.1002/gepi.20390

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  22 in total

1.  Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations.

Authors:  T Wagner; D Stoppa-Lyonnet; E Fleischmann; D Muhr; S Pagès; T Sandberg; V Caux; R Moeslinger; G Langbauer; A Borg; P Oefner
Journal:  Genomics       Date:  1999-12-15       Impact factor: 5.736

2.  Sensitivity and predictive value of criteria for p53 germline mutation screening.

Authors:  A Chompret; A Abel; D Stoppa-Lyonnet; L Brugiéres; S Pagés; J Feunteun; C Bonaïti-Pellié
Journal:  J Med Genet       Date:  2001-01       Impact factor: 6.318

3.  Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families.

Authors:  V Planté-Bordeneuve; J Carayol; A Ferreira; D Adams; F Clerget-Darpoux; M Misrahi; G Said; C Bonaïti-Pellié
Journal:  J Med Genet       Date:  2003-11       Impact factor: 6.318

4.  Optimal designs for estimating penetrance of rare mutations of a disease-susceptibility gene.

Authors:  Gail Gong; Alice S Whittemore
Journal:  Genet Epidemiol       Date:  2003-04       Impact factor: 2.135

5.  Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset.

Authors:  Jérôme Carayol; Catherine Bonaïti-Pellié
Journal:  Genet Epidemiol       Date:  2004-09       Impact factor: 2.135

6.  Ascertainment in the sequential sampling of pedigrees.

Authors:  C Cannings; E A Thompson
Journal:  Clin Genet       Date:  1977-10       Impact factor: 4.438

7.  A general model for the genetic analysis of pedigree data.

Authors:  R C Elston; J Stewart
Journal:  Hum Hered       Date:  1971       Impact factor: 0.444

8.  Hereditary non-polyposis colorectal cancer: current risks of colorectal cancer largely overestimated.

Authors:  J Carayol; M Khlat; J Maccario; C Bonaïti-Pellié
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

9.  Estimating cancer risk in HNPCC by the GRL method.

Authors:  Flora Alarcon; Christine Lasset; Jérôme Carayol; Valérie Bonadona; Hervé Perdry; Françoise Desseigne; Qing Wang; Catherine Bonaïti-Pellié
Journal:  Eur J Hum Genet       Date:  2007-05-02       Impact factor: 4.246

10.  A time-dependent logistic hazard function for modeling variable age of onset in analysis of familial diseases.

Authors:  L Abel; G E Bonney
Journal:  Genet Epidemiol       Date:  1990       Impact factor: 2.135

View more
  5 in total

1.  Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method.

Authors:  Bernard Bonaïti; Valérie Bonadona; Hervé Perdry; Nadine Andrieu; Catherine Bonaïti-Pellié
Journal:  Eur J Hum Genet       Date:  2010-10-06       Impact factor: 4.246

2.  Non-parametric estimation of survival in age-dependent genetic disease and application to the transthyretin-related hereditary amyloidosis.

Authors:  Flora Alarcon; Violaine Planté-Bordeneuve; Malin Olsson; Grégory Nuel
Journal:  PLoS One       Date:  2018-09-25       Impact factor: 3.240

3.  TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?

Authors:  Bernard Bonaïti; Malin Olsson; Urban Hellman; Ole Suhr; Catherine Bonaïti-Pellié; Violaine Planté-Bordeneuve
Journal:  Eur J Hum Genet       Date:  2010-03-17       Impact factor: 4.246

4.  Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy.

Authors:  Hartmut H-J Schmidt; Fabio Barroso; Alejandra González-Duarte; Isabel Conceição; Laura Obici; Denis Keohane; Leslie Amass
Journal:  Muscle Nerve       Date:  2016-09       Impact factor: 3.217

5.  Computing Individual Risks Based on Family History in Genetic Disease in the Presence of Competing Risks.

Authors:  Gregory Nuel; Alexandra Lefebvre; Olivier Bouaziz
Journal:  Comput Math Methods Med       Date:  2017-11-09       Impact factor: 2.238

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.